Back to Agenda
THE EUROPEAN LANDSCAPE ON HTA - THE EUnetHTA JOINT ACTION
Session Chair(s)
Finn Boerlum Kristensen, MD, PhD
Director EUnetHTA Coordinating Secretariat
Danish Health and Medicines Authority, Denmark
The aim of this session is to introduce the current scenarios of HTA in the European context. In particular, three points of view are considered as significant in order to match the highest purposes of dissemination of HTA methods and finalities: the status of the European Network for Health Technology Assessment (EUnetHTA) Joint Action, one of the most collaborative experiences among stakeholders in Europe, the engagement of industry as key partner for institutions to have results in terms of improved medicines and sustainability for healthcare systems and the perspective of patients as the final target of a complex and challenging process.
Speaker(s)
The European landscape on HTA – Update on the EUnetHTA Joint Action
Finn Boerlum Kristensen, MD, PhD
Danish Health and Medicines Authority, Denmark
Director EUnetHTA Coordinating Secretariat
Improving Collaboration between Industry and Regulatory world: HTA as a pivotal challenge to match wider needs
Richard Bergström, MS
European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium
Director General
Eric Low
Myeloma UK, United Kingdom
Chief Executive
Have an account?